Podcast: Compass Files Psilocybin Application with FDA, U.S. Government Taps Mark Cuban to Develop Ibogaine, Psychedelics After the Midterms
In this episode of The Psychedelic News Feed podcast, Psychedelic Alpha’s editor Josh Hardman runs through the last two weeks in the psychedelics field, including these stories:
- Compass Pathways submits its psilocybin new drug application to FDA
- We look at what the midterms might mean for the psychedelics field
- U.S. government taps Mark Cuban to support ibogaine research push
- Delix Therapeutics raises $100M Series C
- Other stories
Read more:
- Breaking: Compass Files Psilocybin for TRD New Drug Application with FDA
- Pα+ Psychedelic Bulletin #234: Psychedelics After the Midterms; FDA Answers House Psychedelics Caucus; ICER to Review Compass’ Psilocybin; Terran v. Compass Gets Trial Date
- Breaking: U.S. Government Taps Mark Cuban’s Company to Develop Ibogaine for PTSD; Commits to Fund $20M Real-World Evidence Network
- 220 Patients or 20,000? Clinics Split on Psychedelics’ First Year